Form 8-K - Current report:
SEC Accession No. 0000950123-07-008898
Filing Date
2007-06-19
Accepted
2007-06-19 16:38:00
Documents
5
Period of Report
2007-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y36240e8vk.htm 8-K 15755
2 EX-10.1: AMENDED AND RESTATED STOCK INCENTIVE PLAN y36240exv10w1.htm EX-10.1 59356
3 EX-99.1: PRESS RELEASE y36240exv99w1.htm EX-99.1 8308
4 EX-99.2: PRESS RELEASE y36240exv99w2.htm EX-99.2 9122
5 GRAPHIC y36240y3624003.gif GRAPHIC 5222
  Complete submission text file 0000950123-07-008898.txt   101581
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 07929121
SIC: 2835 In Vitro & In Vivo Diagnostic Substances